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HIGHLIGHTS 
1. No imaging marker for treatment response of spondylodiscitis (SD) has been proposed. 
2. Volume changes of subcutaneous fluid collection (SFC) had significant correlation 
with changes of C-reactive protein (CRP). 
3. SFC can be used as an imaging marker for treatment response of SD on magnetic 
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Purpose: To evaluate prevalence of subcutaneous fluid collection (SFC) in infectious 
thoracolumbar spondylodiscitis (SD) compared with control patients and to investigate 
correlation between volume changes of SFC and treatment response of SD. 
Materials and methods: This retrospective study was approved by our institutional 
review board. From April 2011 to March 2012, 49 patients (24 SD and 25 non-SD 
patients) were enrolled. Prevalence of SFC was evaluated respectively for SD and 
non-SD patients using magnetic resonance imaging (MRI) on the sagittal short tau 
inversion recovery (STIR) imaging or fat-saturated T2-weighted imaging (T2WI), and 
compared. In SD patients with SFC, correlation was investigated between SFC volume 
on the 1
st
 MRI and initial clinical status. The same analysis was conducted also for SFC 




 or last MRI. 
Results: SFC was found in 20 patients with SD (83.3%) and 3 non-SD patients (12%) 
with significant difference (p< .001). In 20 SD patients with SFC, 17 patients had 
follow-up MRI. For the 1
st
 MRI, no significant correlation was found between volume of 
SFC and initial status of patients, including body weight, body mass index (BMI), white 
blood cell (WBC), and erythrocyte sedimentation rate (ESR). However, significant 







































































 as well as from the 1
st
 to the last MRI (each p < .05). 
Conclusion: SD patients had significantly higher prevalence of SFC than non-SD patients. 
Volume changes of SFC had significant correlation with changes of CRP, which can be 
used as an imaging marker for treatment response of SD on MRI. 
 
Keywords: spondylodiscitis, vertebral osteomyelitis, subcutaneous fluid collection, 
C-reactive protein, magnetic resonance imaging, short tau inversion recovery. 
 
Abbreviations: ANOVA, analysis of variance; BI, Barthel Index; BMI, body mass index; 
BW, body weight; CRP, C-reactive protein; DICOM, digital imaging and communication 
in medicine; DM, diabetes mellitus; ESR, erythrocyte sedimentation rate; FIM, 
Functional Independence Measure; ICC, intra-class correlation coefficient; MRI, 
magnetic resonance imaging; ROI, region of interest; SD, spondylodiscitis; SFC, 
subcutaneous fluid collection; STIR, short tau inversion recovery; T1WI, T1-weighted 





































































Infectious spondylodiscitis (SD) is an infection of the vertebral body and the 
adjacent intervertebral disc. Annual incidence of SD was estimated between 1:42,000 and 
450,000 cases 
1
 and is currently increasing because of increase in elderly population with 
diabetes mellitus (DM) and immunocompromised status 
2
. Magnetic resonance imaging ) 
is highly sensitive for detecting SD 
3
; however, it is not predictive of the treatment 
response, because high signal intensity of the vertebral body and the adjacent 
intervertebral disc space on T2-weighted imaging (T2WI) or short tau inversion recovery 
(STIR) imaging remains even after clinical improvement 
4, 5
. For observation of 
therapeutic response of SD, C-reactive protein (CRP) and erythrocyte sedimentation rate 
(ESR) are superior to other biological data such as white blood cell (WBC) 
5-7
, although 
ESR is affected by many factors
8
. No imaging marker has been proposed for this purpose.  
In MRI, subcutaneous fluid collection (SFC) is an occasional finding seen at 
the deep layer of subcutaneous adipose tissue of the back 
9
, and it has been reported to be 
associated with increasing weight in patients with degenerative disc disease or 
radiculopathy 
10
. In our clinical experience, SFC is more commonly seen in patients with 
SD when compared with patients without SD. However, to our knowledge, its clinical 



































































In this study, we retrospectively analyzed prevalence of SFC in patients who 
underwent thoracolumbar MRI for SD and non-SD conditions, and investigated clinical 
significance of SFC in SD patients, specifically relationship between SFC volume and 
clinical status including blood data, so as to examine if SFC could be an imaging 
predictor for treatment response or outcome in patients with SD.  
 
2. Materials and methods 
This study was approved by the institutional review board, and informed 
consent was waived due to retrospective nature of this study.  
 
2.1. Patients with infectious spondylodiscitis (Table 1) 
Patients clinically suspected of infectious thoracolumbar SD were searched 
from April 2011 to March 2012, and 30 patients who underwent MRI with clinical 
diagnosis of SD were found. Patients who had a prior thoracolumbar surgery, bone tumor, 
acute compression fracture without osteomyelitis, and paraspinal or cutaneous disorders 
were excluded from this study.  
 The diagnosis of infectious SD was made by the following criteria: (i) clinical 



































































SD (see 2.5. Image analysis). These criteria were applied to the patients clinically 
suspected of infectious thoracolumbar SD. Bacteriological cultures of blood, disc or soft 
tissue mass such as paravertebral and psoas abscess were also examined, but positive 
proof was not considered mandatory due to imperfect sensitivity. Microorganisms were 
found at the specimen obtained from local lesions of infected disc or abscesses of 
soft-tissue such as psoas muscle in 7 patients (29%). Blood culture was taken from all but 
one patient, and 14 patients (58.3%) were positive. Two patients were positive for 
mycobacterium tuberculosis from sputum culture with pathological finding consistent 
with mycobacterium tuberculosis from disc and bone marrow samples (Table 2). There 
was positive overlap of cultures from local lesion and blood in 4 cases.  
 Of 30 patients, five patients were not considered SD and one patient was 
excluded due to complete bedridden condition caused by a traffic accident. Finally, 24 
patients (13 males and 11 females; mean age 74.6 years old, ranged from 59 to 89 years 
old) were included as SD patients in this study.  
 
2.2. Control patients 
Non-SD patients were searched in the reporting system from April 2011 until 



































































body mass index (BMI) were found, and 25 control patients (11 males and 14 females; 
mean 65.6 years old, ranged from 28 to 95 years old) were enrolled. They were almost 
normal except having spondyloradiculopathy findings. No finding of a prior 
thoracolumbar surgery, bone tumor, acute compression fracture, osteomyelitis, discitis, 
and paraspinal or cutaneous disorders was observed.  
 
2.3. Clinical data 
The following data were collected in each SD patient at the initial medical 
examination: (i) BW and BMI, (ii) symptoms (fever, back pain, difficulty in walking, 
etc.), (iii) initial mobility status (walk, on wheelchair or bed ridden), (iv) comorbidity of 
DM and immunocompromised status, (v) antibiotic treatment before 1
st
 MRI, (vi) blood 
data (WBC, CRP and ESR), and (vii) bacteriological data. Blood data on the day nearest 
to follow-up MR examinations were also collected if available, noting intervals from the 
first blood test (WBC, 1.4 ± 2.8 days; CRP, 1.3 ± 2.7 days; ESR, 2.8 ± 3.6 days). The 
Barthel Index (BI) score that measures the patient’s performance in 10 activities of daily 
life 
11
 and the Functional Independence Measure (FIM) motor score that evaluate 18 
items 
12
 on the day nearest (within 15 days) to initial and follow-up MR examinations 






































































MRI studies were performed using 1.5T scanners (Magnetom Avanto and 
Vision, Siemens Medical Systems, Erlangen, Germany) with the following sequences: 
sagittal T1-weighted imaging (T1WI; TR/TE, 400-800ms/8-12ms; slice thickness, 4 mm; 
inter-slice gap, 1 mm; field-of-view, 280×280 mm; matrix size 256×256), sagittal 
T2-weighted imaging (T2WI; TR/TE, 3635-4604ms/95-120ms; slice thickness, 4 mm; 
inter-slice gap, 1 mm; field-of-view, 280×280 mm; matrix size 384-512×384-512), and 
sagittal STIR imaging (TR/TE, 4790/110; inversion time, 130 milliseconds; slice 
thickness, 4 mm; inter-slice gap, 1 mm; field-of-view, 300×300 mm; matrix size 
320-384×320-384) or sagittal fat-saturated T2WI (TR/TE, 4590/60; slice thickness, 4 
mm; inter-slice gap, 1 mm; field-of-view, 300×300 mm; matrix size 384-512×384-512). 
Also conducted was axial T2WI (TR/TE, 4362-4604ms/95-120ms; slice thickness, 4 
mm; inter-slice gap, 1 mm; field-of-view, 180×180 mm; matrix size 384-512×384-512).  
 
2.5. Image Analysis 



































































diagnostic imaging for 9 years). Spondylitis (i.e. vertebral osteomyelitis) was defined as 
presence of hypointensity on T1WI and hyperintensity on STIR or fat-saturated T2WI 
within the vertebral bone marrow 
13, 14
. Discitis was defined as presence of hyperintensity 
within the intervertebral disc on STIR or fat-saturated T2WI 
14
. SD was defined as 
presence of discitis and osteomyelitis above and below of the affected disc 
15
. Clinical 
symptoms and blood data were also taken into consideration for diagnosis of SD. 
Epidural, paravertebral and psoas abscess were focal hypointensity on T1WI and 
fluid-equivalent signal intensity on T2WI, fat-saturated T2WI or STIR imaging 
13, 16
.  
SFC was defined as fluid-equivalent signal intensity located at the deep layer of 
subcutaneous adipose tissue that consists of two layers (i.e. superficial and deep layers) 
9
. 
Volume measurement of SFC was conducted on the sagittal fat-saturated T2WI or STIR 
images using a digital imaging and communication in medicine (DICOM) viewer (OsiriX, 
ver. 5.7.1; http://www.osirix-viewer.com/Downloads.html). Region of interest (ROI) was 
semi-automatically selected using region growing method of high signal intensity area on 
STIR or fat-saturated T2WI. SFC volumes on follow-up MRI were also measured, and 
imaging intervals were noted. The measurements were conducted twice as separate 
sessions, and the paired measurement values were averaged for further analysis 
17
. Other 



































































and noted.  
 
2.6. Statistical Analysis 
Positive rates of SFC were calculated separately for SD and non-SD patients, 
and difference was examined using Fisher’s exact test. For SFC volume measurements, 
intra-observer variability was evaluated using intra-class correlation coefficient (ICC) of 






. In SD patients, relations between 
presence of SFC and initial status (walk, on wheelchair or bedridden) were analyzed 
using analysis of variance (ANOVA). Correlational analysis was conducted between SFC 
volumes on the 1
st
 MRI and corresponding scores of BI, FIM motor, BW, BMI and blood 




or last MRI were also analyzed. Differences 
in SFC frequency by abovementioned comorbid conditions were examined using 
Mann-Whitney U tests. A p value less than .05 was considered statistically significant. 
Statistical analysis was conducted with a commercially available statistical software 
package (MedCalc version 13.1.2; MedCalc Software, Ostend, Belgium). 
 
3. Results 



































































Twenty SD patients (9 males and 11 females) showed SFC on the 1
st
 MRI 
(83.3%), whereas 3 non-SD patients (1 male and 2 females) showed SFC (12.0 %), and 
the difference was statistically significant (P < .001). Mean BW and BMI of 25 non-SD 
patients were 54.6 ± 12.2 kg and 21.3 ± 3.4 kg/m
2
, respectively. Those of 24 SD patients 
were 57.8 ± 18.6 kg and 23.2 ± 7.0 kg/m
2
, and no statistically significant difference was 
observed.  
 
3.2. Correlation of clinical symptoms and blood data with SFC volume in SD patients 
Initial symptoms were back pain (n = 9), fever (n = 5), back pain & fever (n = 8), 
and others (n = 2). Initial status of patients was divided into three groups: walk (n = 6), on 
wheelchair (n = 2) or bedridden (n = 16). Patients had one or more comorbid conditions: 
DM (n = 10), chronic renal disease (n = 5) and chronic liver disease (n = 5). There were 
prednisolone users (n = 4). Fifteen patients were given antibiotics before initial MRI (14 
patients with intravenous antibiotics and 1 patient with oral antibiotics). Mean WBC, 
CRP and ESR in each time were shown in supplementary Table 1. No significant 
correlation was found between volume of SFC on the 1
st
 MRI and clinical symptoms, 




































































3.3. Imaging findings of the 1
st
 MRI in SD patients 
The site mostly involved sites with SD lesions were the lumbar area. Some had 
infection extending to the surrounding structures including the psoas muscle. The 
characteristics of SD and other infectious lesion of the 1
st
 MRI are summarized in Table 
3.  
 
3.4. SFC volume and its correlates 
In 20 SD patients with SFC, 17 patients had follow-up MRI. Nine, 5, 2 patients 








 MRI, respectively. Intervals from 
initial MRI were 24.4 ± 16.5, 38.9 ± 25, 71.3 ± 19.9 and 115 days, respectively. ICC of 




MRI was 0.98, which was recognized as very 
good intra-observer reproducibility 
18
.  
There was no relationship between presence of SFC on 1
st
 MRI and initial 
mobility status (walk, on wheelchair or bedridden) of patients. Analysis between SFC 
volumes on 1
st
 MRI and clinical data (BW, BMI, blood data and scores of the BI or FIM 
motor) found no statistically significant correlation. No significant correlation was 








































































MRI by comorbidity. 
However, significant positive linear correlations were found between changes 




 or last MRI and CRP (x, SFC volume change; y, CRP; y 
= 1.1035x + 3.8547, R
2 
= 0.60, p = .001 and y = 0.9099x + 5.4561, R
2 
= 0.43, p = .01, 
respectively; See Fig. 1). No significant correlation was found with changes of WBC or 
ESR. Plot of averages of SFC volume and blood inflammatory markers of WBC, CRP 




 MRI in 8 patients shows a similar trend between volume of 
SFC and CRP (Fig. 2). Representative cases are presented in Figs. 3 and 4.  
 
4. DISCUSSION 
Subcutaneous adipose tissue consists of two layers of superficial and deep 
layers 
9
, and SFC is observed at the deep layer. These layers are structurally different. Fat 
lobules of the superficial layer are small and tightly packed within closely spaced septa, 
whereas those of the deep layer are large, sparse and much less organized 
9
. Such 
anatomical difference in anatomy is considered to be one of the reasons for fluid 
collection.  
In their investigation of non-SD patients, Shi et al. reported that degree of fluid 





































































. In their low-weight subgroup, the prevalence of SFC was less than the 
obese group and was similar to that of the non-SD patients in our study. They speculated 
pathophysiology of SFC in obese patients was: (1) increased pressure of inferior vena 
cava due to increased intra-abdominal pressure followed by increased peripheral and 
capillary pressure, (2) increased circulatory volume and intravascular pressure due to 
obesity, and (3) increased peripheral capillary blood flow and permeability caused by 
reduced cutaneous vasoconstriction response to sympathetic activation in obese patients. 
In our study, however, there was no correlation between volumes of SFC on the 1
st
 MRI 
and BW or BMI in SD patients. This result suggests presence of other factors related to 
SFC.  
In SD patients, decreased body movement may contribute to formation of SFC. 
However, no significant correlation was found between physical conditions or BI/FIM 
motor indices and SFC. The same was the case for comorbidities of DM and others. 
These results may suggest presence of some specific mechanism for SFC in this study. 
SD may cause impairment of the vessels and lymphatics around the vertebra, leading to 
decreased lymphatic drainage. Such changes may increase permeability of not only 
vessel around vertebra, but also that of subcutaneous adipose tissue, because the lumbar 





































































of SD may spread to the structures around posterior portion of vertebra such as Facet joint, 
spinous process and erector spinae muscle. This may be one of the reasons for appearance 
of SFC.  
Volume measurement of SFC was conducted using region growing method by 
Osirix. This method is relatively easy to select ROI semi-automatically and could be 
acceptable broadly, because ICC of SFC volume measurement that was conducted twice 
was very good. 
No correlation was found between all biological data, including WBC, CRP 
and ESR, and SFC volume on the 1
st
 MRI. It was probably because these values varied 









MRI, significant relationships were observed correlated to 
corresponding changes in CRP, which normalizes quickly and is helpful in tracking 
recovery from SD 
2, 7, 20
. As in Fig. 2, SFC volume changes are parallel to those of CRP, 
especially at the early stage, which relationship may make SFC volume changes an 
imaging marker for improvement of local inflammation.  
No correlation was found between SFC volume changes and those of WBC or 
ESR. WBC isn’t elevated in all patients with spinal infection and is often only slight 
elevated to normal in elderly and immunocompromised patients 
2



































































significant trend during treatment 
21
. ESR is elevated in higher rate and is thought as 
useful marker 
7, 21-23
. However, ESR may remain elevated to some degree for as long as 6 
months in up to 75% of patients 
24. All patients don’t show complete fall of ESR values 
after successful treatment. Therefore, persistent elevation of ESR doesn’t necessarily 
indicate treatment failure 
21
. Relatively slow reduction of ESR can also be observed in our 
results (see Fig. 2). 
Limitations in this study include its retrospective nature and relatively small 
sample size. We could not acquire the constant follow-up MRI and biological data of all 
patients. We need further prospective study with larger populations. We couldn’t obtain 
the all specimen from local lesions because of patient conditions. We should identify the 
microorganisims to diagnose SD definitely for all cases, but 15 SD patients were treated 
with antibiotics before the initial MRI. Although MRI should be performed before 
treatment, it may be difficult to do so on the acutely ill patients considering priority of 
treatment. 
5. Conclusions 
In conclusion, there has been no imaging marker for improvement of SD, 
despite increasing use of follow-up MRI examinations. In patients with SD, volume 



































































treatment response by imaging.  
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Fig. 1. Scatterplot of ΔCRP andΔvolume of SFC using difference values with 









MRI (B) is statistically significant (each p 
< .05). 
 





 MRI). We show the good relationships between volume of SFC and CRP. Values of 
WBC and ESR are indicated as each a thousandth and a tenth values.  
 
Fig. 3. Seventy-one years old male with L4/5 discitis, epidural abscess at the level of L4/5 
(not shown), and bilateral psoas abscess. Initial sagittal STIR image shows hyperintensity 
in the disc of L4/5 (A, arrowhead). Massive SFC is also seen (A, arrow). Hyperintensity 
in the disc of L5/S is physiological signal intensity. Axial T2WI shows bilateral psoas 
abscess (B, asterisk). On follow-up sagittal STIR (C) (11 days after treatment), 
hyperintensity in the disc of L4/5 disappears. Volume of SFC decreases (C, arrow). 
Improvement of right psoas abscess is also seen on follow-up axial T2WI after drainage 



































































the initial state to 1.9 mg/dl at 11 days after treatment.  
 
Fig. 4 Sixty-six years old female with spondylodiscitis and prevertebral abscess 
(arrowhead) at and around Th5/6 on the initial STIR image (A). SFC is seen (A, arrow). 
Old compression fracture in Th10 is also shown. On follow-up sagittal STIR (B) (6 days 
after treatment), hyperintensity in Th5/6 and prevertebral space remains (arrowhead), but 
SFC disappears. In this case, CRP values decreased from 27.20 mg/dl to 5.6 mg/dl. 
 















23.2 ± 7 
Initial symptom presentation 
   Back pain 9 
  Fever 5 
  Back pain + Fever 8 
  Others 2 
Initial status 
   Walk 6 
  Wheelchair 2 
  Bedridden 16 
Comorbidity 
   DM 10 
  CRF 5 
  Chronic liver disease 5 
  PSL user 4 




   Yes 15 
  No 9 
BMI: body mass index, CRF: chronic renal failure, DM: diabetes mellitus,  
MRI: Magnetic resonance imaging, PSL: prednisolone. aRange, bMean ± SD.  
 
Table 1
Table 2 Culture results and identified microorganism.  
Variable N 
Culture from local lesion 
   Positive 7 
  Negative 5 
  Not performed 12 
Blood culture 
   Positive 14 
  Negative 9 
  Not performed 1 
Positive culture from local lesion 
  MSSA 1 
  Strptococcus bovis 1 
  Candida tropicalis 1 
  Escherichia coli 1 
  Klebsiella pneumoniae 1 
  Alpha-Streptococcus 1 
  Actinomyces spieces 1 
Positive blood culture 
   MSSA 5 
  MRSA 2 
  Alpha-Streptococcus 2 
  Escherichia coli 2 
  Streptococcus agalactiae 1 
  Strptococcus bovis 1 
  Strptococcus dysgalactiae 1 
Sputum culture 
   Mycobacterium tuberculosis 2 
MRSA: methicillin-resistant Staphylococcus aureus, MSSA: methicillin-sensitive Staphylococcus aureus. There was positive overlap 
of cultures from local lesion and blood in 4 cases.  
 
Table 2
Table 3 The characteristics of spondylodiscits and other infectious lesion on the 1
st
 MRI.  
Variable N 
Site of involvement 
   Thoracic 5 
  Lumbar 18 
  Thoracic + Lumbar 1 
SD vs D (Mono:Multiple) 
   Only D 4 (3:1) 
  Only SD 15 (13:2) 
  Only S 3 (1:2) 
  SD + D 2 
Other infectious lesion 
   Epidural 4 
  Prevertebral 4 
  Psoas 7 
  Multiple 4 
D: discitis, S: spondylitis, SD: spondylodiscitis.  
SD + D means spondylodiscitis with discitis of other level. 
Multiple means more than 2 infectious lesions. 
 
Table 3
Supplementary Table 1 Mean WBC, CRP and ESR of all Patients.  
 
1st 2nd 3rd 4th 5th 
WBC 
(µl) 
11,071 ± 4,932 
(24) 
7,742 ± 3,294 
(14) 
6,975 ± 3,445 
(8) 






12.86 ± 12.08 
(23) 
4.30 ± 4.32 
(15) 
2.59 ± 3.97 
(8) 






85.1 ± 32.6 
(22) 
77.3 ± 40.5 
(14) 
76.1 ± 40.8 
(8) 




WBC: white blood cell, CRP: C-reactive protein, ESR: erythrocyte sedimentation rate. Values are presented as mean ± SD, and in 
the parentheses are numbers of patients.  
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